Cargando…
Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: rationale and design of SHIFT‐AHF trial
AIMS: Elevated heart rate (HR) in heart failure (HF) is associated with worse outcomes, particularly in acute HF (AHF). HR reduction with ivabradine reduces cardiovascular events in HF patients with reduced ejection fraction. The present trial aimed to test the hypothesis that the early HR reduction...
Autores principales: | Su, Yang, Ma, Teng, Wang, Zeyu, Dong, Bin, Tai, Chenhui, Wang, Hao, Zhang, Fenglei, Yan, Chunxi, Chen, Wei, Xu, Yawei, Ye, Lei, Tye, Gee Jun, Ong, Sang‐Bing, Zhang, Jian, Xu, Dachun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754724/ https://www.ncbi.nlm.nih.gov/pubmed/32945150 http://dx.doi.org/10.1002/ehf2.12997 |
Ejemplares similares
-
Rationale and design of the AUGUST‐AHF Study
por: Zhang, Jingjing, et al.
Publicado: (2020) -
Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR‐AHF
por: Palazzuoli, Alberto, et al.
Publicado: (2017) -
Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX‐AHF‐2 study
por: Teerlink, John R., et al.
Publicado: (2017) -
Comment on: Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: Rationale and design of SHIFT‐AHF trial
por: Imamura, Teruhiko, et al.
Publicado: (2021) -
Natriuresis‐guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium‐based treatment algoritHm in Acute Heart Failure (PUSH‐AHF) trial
por: ter Maaten, Jozine M., et al.
Publicado: (2022)